NCT01789268View on ClinicalTrials.gov

Impact of Respiratory Pathogens in Infants

CompletedOBSERVATIONAL
Enrollment

267

Participants

Timeline

Start Date

March 27, 2013

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Respiratory Tract Infection
Interventions
DEVICE

Respiratory Inductive Plethysmography

Respiratory Inductive Plethysmography (RIP) will be used to document thoracoabdominal motion, relative minute ventilation, and apnea during the minimally invasive respiratory assessments (NIRAs). Both Full and Preterm Infants will undergo a respiratory assessment via RIP prior to and after a bronchodilator (albuterol)

Trial Locations (1)

14642-0001

University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Rochester

OTHER

NCT01789268 - Impact of Respiratory Pathogens in Infants | Biotech Hunter | Biotech Hunter